ANAB
AnaptysBio Inc
45.70$
-4.7%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -1,099.3% | -381.4% | -518.9% | -194.3% | -33.6% | -154.6% | -38.5% | -180.8% | -35.8% | 90.5% | -101.4% | -96.9% | 7.6% | |
| 17.8% | 6.7% | 8.4% | 5.4% | 2.0% | 1.4% | 2.2% | 2.7% | 0.8% | 0.6% | 2.4% | 1.3% | 0.9% | |
| 235.3% | 90.1% | 141.1% | 68.8% | 27.3% | 19.0% | 33.0% | 41.5% | 12.0% | 7.9% | 55.6% | -21.5% | 10.9% | |
| 278.6% | – | – | – | – | – | – | – | – | – | – | – | – | |
| -271.3% | -29.5% | -103.1% | 79.5% | -4.4% | -159.5% | 8.9% | -132.3% | -96.5% | 18.4% | -30.2% | -130.4% | -40.9% | |
| 4.9% | 3.1% | 0.4% | 0.3% | 0.1% | 0.6% | 0.1% | 0.2% | 0.0% | 0.0% | 0.1% | 0.1% | 0.0% | |
| 923.3% | 546.1% | 955.8% | -22.3% | 195.3% | -68.2% | 53.5% | 163.5% | 135.3% | 67.9% | 136.9% | 27.5% | 92.3% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | -1.1% | -15.9% | -229.5% | -12.7% | -3.1% | 0.0% | – | – | |
| -92.6% | -57.3% | -189.9% | 381.8% | 237.3% | 63.9% | -102.9% | -226.8% | -13.6% | -39.8% | 4.7% | -347.7% | -62.2% | |
| -268.6% | 107.4% | 247.0% | 165.2% | 399.0% | -158.9% | -88.0% | -244.1% | 85.9% | 118.6% | 40.2% | -417.1% | 37.7% | |
| -1,104.2% | -384.6% | -519.3% | -194.6% | -33.7% | -155.3% | -38.7% | -180.9% | -35.9% | 90.5% | -101.5% | -96.9% | 7.6% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.